摘要:
This invention relates to newly identified compounds for inhibiting hYAK3 and/or CK2 proteins and methods for treating diseases associated with the imbalance or inappropriate activity of hYAK3 and/or CK2 proteins.
摘要:
A metallocene complex by which high uptake efficiency of ethylene and/or α-olefin can be obtained compared with the conventional metallocene catalyst, and robber component having high molecular weight can be polymerized, and polymerization method of olefin. Metallocene complex (metallocene complex having furyl or thienyl group in which substituent exists at 5-position of indenyl ring, and substituent may exist at 2-position of indenyl ring, and the like) represented by the general formula [II], the catalyst for olefin polymerization characterized by comprising said metallocene complex, and polymerization method of olefin characterized that polymerization or copolymerization of olefin is carried out using said polymerization catalyst for olefin, and the like.
摘要:
Laundry detergents or cleaning compositions which comprises a copolymer composition comprising i) a copolymer having a weight-average molecular weight of from about 10,000 to about 50,000 and comprising a) 30-60 mol% structural units derived from monoethylenically unsaturated dicarboxylic acid or dicarboxylate; b) structural units derived from monoethylenically unsaturated monocarboxylic acid or monocarboxylate; c) structural units derived from monomers containing sulfonic acid or sulfonate groups and having no ester bonds or amido bonds; and ii) 10,000 ppm or less of residual monoethylenically unsaturated dicarboxylic acid or dicarboxylate monomer.
摘要:
Metallocene compounds represented by the following general formula (1): YqKLMX2 (1) wherein M, Y, q, L and X are each as defined in the Specification.
摘要:
There are disclosed a (meth)acrylic copolymer and its production process, wherein the (meth)acrylic copolymer has the good chelating ability and dispersibility and is excellent both in the calcium-ion-binding ability and the gelation resistance in combination, and further, the deterioration of these various performances is inhibited even in the water system of high salt concentration. The (meth)acrylic copolymer comprises a constitutional unit (a) derivative from a specific (meth)acrylic monomer (A) and a constitutional unit (b1) derivative from a specific (meth)allyl-etheric monomer (B1) and has a phosphorus atom in the main chain; with the (meth)acrylic copolymer being characterized by having: a mutual ratio between the constitutional unit (a) and the constitutional unit (b1) in the specific range; a low molecular weight; and a content of phosphorus, as bonded to the copolymer, in the predetermined range; and further a gelation resistance of not more than 0.02 and a calcium-ion-binding ability of not less than 150 mgCaCO3/g.
摘要:
A metallocene compound is provided wherein to a transition metal compound is bonded a multidentate compound wherein a substituted cycloalkadienyl ring CA1 having therein a heteroaromatic group Ra containing an oxygen, sulfur or nitrogen atom on a cycloalkadienyl ring, preferably the five-membered ring thereof, and an unsubstituted or substituted cycloalkadienyl group CA2 or —(R1)N—, —O—, —S— or —(R1)P—, preferably CA2, more preferably a substituted cycloalkadienyl group identical with CA1 are bonded through a divalent linking group. The metallocene compound is suitable as a principal ingredient of a catalyst for the polymerization of olefins, particularly achieving a very high effect in making the molecular weight of a polypropylene higher.
摘要:
The present invention provides an N-substituted acylamino acid compound of the formula: ##STR1## a process for their production and pharmaceutical uses, and intermediates useful for their production.
摘要:
An N-acylamino acid derivative of the formula: ##STR1## wherein each of R.sup.1, R.sup.2, R.sup.4 and R.sup.6 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms; each of R.sup.3 and R.sup.5 is hydrogen or lower alkyl; A is --CH(OH)--(CH.sub.2).sub.q R.sup.7 wherein R.sup.7 is hydrogen, lower alkyl, cycloalkyl, cyloalkylalkyl, aryl, aralkyl, a-monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms or --E--R.sup.10 wherein E is --S(O).sub.i -- wherein i is 0, 1 or 2, oxygen, --NR.sup.11 -- wherein R.sup.11 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, or ##STR2## wherein each of R.sup.12 and R.sup.13 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl, and R.sup.10 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms provided that when R.sup.10 is hydrogen, i is 0, and a is an integer of from 0 to 5; or --CH.sub.2 --CHR.sup.8 --CO--R.sup.9 wherein R.sup.8 is hydrogen, lower alkyl, cycloalkyl, cycloalkylakyl, aryl, aralkyl or a monocyclic or bicyclic heterocyclic group containing from 1 to 4 hetero atoms, and R.sup.9 is hydroxyl, --OX wherein, X is alkyl aryl, lower alkoxycarbonyloxyalkyl or 1-phthalidyl, or --N(Y.sup.1)(Y.sup.2 ) wherein each of Y.sup.1 and Y.sup.2 is hydrogen, lower alkyl, aryl, aralkyl or cycloalkyl, or Y.sup.1 and Y.sup.2 form together with the adjacent nitrogen atom a 5- or 6-membered heterocyclic group which may contain a further hetero from; m is 0, 1 or 2; and n is an integer of from 1 to 5, provided that when R.sup.1 is hydrogen, m is 0; or a salt thereof, which is useful as hypotensive drugs.